{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T09:10:04Z","timestamp":1734340204233,"version":"3.30.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,16]]},"DOI":"10.7759\/cureus.75778","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T08:30:08Z","timestamp":1734337808000},"source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of Acetazolamide in Patients With Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Sanjay","family":"Eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mian M","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhuja","family":"Sompalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keron","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandipkumar S","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin R","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danish","family":"Allahwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-022-00576-9","article-title":"\u2018Acute heart failure\u2019: should we abandon the term altogether?","volume":"19","author":"Straw S","year":"2022","unstructured":"Straw S, Napp A, Witte KK. \u2018Acute heart failure\u2019: should we abandon the term altogether?. Curr Heart Fail Rep. 2022, 19:425-434. 10.1007\/s11897-022-00576-9","journal-title":"Curr Heart Fail Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06586-4","article-title":"Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer","volume":"193","author":"Kwan ML","year":"2022","unstructured":"Kwan ML, Cheng RK, Iribarren C, et al.. Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022, 193:669-675. 10.1007\/s10549-022-06586-4","journal-title":"Breast Cancer Res Treat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13061674","article-title":"The changing role of loop diuretics in heart failure management across the last century","volume":"13","author":"Palazzuoli A","year":"2024","unstructured":"Palazzuoli A, Mazzeo P, Fortunato M, et al.. The changing role of loop diuretics in heart failure management across the last century. J Clin Med. 2024, 13:1674. 10.3390\/jcm13061674","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker GM","year":"2020","unstructured":"Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:1178-1195. 10.1016\/j.jacc.2019.12.059","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44624","article-title":"Combination diuretic therapy with thiazides: a systematic review on the beneficial approach to overcome refractory fluid overload in heart failure","volume":"15","author":"Gogikar A","year":"2023","unstructured":"Gogikar A, Nanda A, Janga LS, Sambe HG, Yasir M, Man RK, Mohammed L. Combination diuretic therapy with thiazides: a systematic review on the beneficial approach to overcome refractory fluid overload in heart failure. Cureus. 2023, 15:e44624. 10.7759\/cureus.44624","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010288","article-title":"Unlocking the potential of acetazolamide: a literature review of an adjunctive approach in heart failure management","volume":"13","author":"Sabina M","year":"2024","unstructured":"Sabina M, Barakat Z, Feliciano A, Lamb A, Alsamman MM. Unlocking the potential of acetazolamide: a literature review of an adjunctive approach in heart failure management. J Clin Med. 2024, 13:288. 10.3390\/jcm13010288","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20585","article-title":"Acetazolamide acts directly on the human skeletal muscle chloride channel","volume":"34","author":"Eguchi H","year":"2006","unstructured":"Eguchi H, Tsujino A, Kaibara M, Hayashi H, Shirabe S, Taniyama K, Eguchi K. Acetazolamide acts directly on the human skeletal muscle chloride channel. Muscle Nerve. 2006, 34:292-297. 10.1002\/mus.20585","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030349","article-title":"Acetazolamide therapy in patients with heart failure: a meta-analysis","volume":"8","author":"Wongboonsin J","year":"2019","unstructured":"Wongboonsin J, Thongprayoon C, Bathini T, Ungprasert P, Aeddula NR, Mao MA, Cheungpasitporn W. Acetazolamide therapy in patients with heart failure: a meta-analysis. J Clin Med. 2019, 8:349. 10.3390\/jcm8030349","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231154603","article-title":"Intravenous or oral acetazolamide for treatment of diuretic-induced alkalosis in patients with heart failure","volume":"57","author":"Addison JD","year":"2023","unstructured":"Addison JD, Peterson EJ, Meyenburg L. Intravenous or oral acetazolamide for treatment of diuretic-induced alkalosis in patients with heart failure. Ann Pharmacother. 2023, 57:1241-1247. 10.1177\/10600280231154603","journal-title":"Ann Pharmacother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0577-1","article-title":"Acetazolamide as add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study","volume":"37","author":"Imiela T","year":"2017","unstructured":"Imiela T, Budaj A. Acetazolamide as add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study. Clin Drug Investig. 2017, 37:1175-1181. 10.1007\/s40261-017-0577-1","journal-title":"Clin Drug Investig"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens W","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, et al.. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022, 387:1185-1195. 10.1056\/NEJMoa2203094","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance","volume":"21","author":"Verbrugge FH","year":"2019","unstructured":"Verbrugge FH, Martens P, Ameloot K, et al.. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail. 2019, 21:1415-1422. 10.1002\/ejhf.1478","journal-title":"Eur J Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37792","article-title":"Effect of acetazolamide as add-on diuretic therapy in patients with heart failure: a meta-analysis","volume":"15","author":"Malik BA","year":"2023","unstructured":"Malik BA, Nnodebe I, Fayaz A, et al.. Effect of acetazolamide as add-on diuretic therapy in patients with heart failure: a meta-analysis. Cureus. 2023, 15:e37792. 10.7759\/cureus.37792","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16526","article-title":"Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study","volume":"133","author":"Kosiorek A","year":"2023","unstructured":"Kosiorek A, Urban S, Detyna J, Biegus J, Hurkacz M, Zymli\u0144ski R. Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study. Pol Arch Intern Med. 2023, 133:10.20452\/pamw.16526","journal-title":"Pol Arch Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2022.11.007","article-title":"CANDI study: chlorthalidone vs acetazolamide in patients with diuretic resistance in acute heart failure","volume":"76","author":"Vela Mart\u00edn P","year":"2023","unstructured":"Vela Mart\u00edn P, Matutano Mu\u00f1oz A, S\u00e1nchez Ortiz D, Dom\u00ednguez F, Royuela A, Cobo Marcos M. CANDI study: chlorthalidone vs acetazolamide in patients with diuretic resistance in acute heart failure. Rev Esp Cardiol (Engl Ed). 2023, 76:477-480. 10.1016\/j.rec.2022.11.007","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123421","article-title":"Acetazolamide tolerance in acute decompensated heart failure: an observational study","volume":"13","author":"Sosa Mercado I","year":"2024","unstructured":"Sosa Mercado I, Putot S, Fertu E, Putot A. Acetazolamide tolerance in acute decompensated heart failure: an observational study. J Clin Med. 2024, 13:3421. 10.3390\/jcm13123421","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/ac.70.3.3080630","article-title":"Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload","volume":"70","author":"Verbrugge FH","year":"2015","unstructured":"Verbrugge FH, Dupont M, Bertrand PB, et al.. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol. 2015, 70:265-273. 10.1080\/ac.70.3.3080630","journal-title":"Acta Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2291336","article-title":"Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship","volume":"39","author":"Tsikas D","year":"2024","unstructured":"Tsikas D. Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship. J Enzyme Inhib Med Chem. 2024, 39:2291336. 10.1080\/14756366.2023.2291336","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010012","article-title":"Congestion in heart failure: from the secret of a mummy to today\u2019s novel diagnostic and therapeutic approaches: a comprehensive review","volume":"13","author":"Alevroudis I","year":"2023","unstructured":"Alevroudis I, Kotoulas SC, Tzikas S, Vassilikos V. Congestion in heart failure: from the secret of a mummy to today\u2019s novel diagnostic and therapeutic approaches: a comprehensive review. J Clin Med. 2023, 13:12. 10.3390\/jcm13010012","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-024-10417-7","article-title":"Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Milbradt TL","year":"2024","unstructured":"Milbradt TL, Sudo RY, Gobbo MO, Akinfenwa S, Moura B. Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials. Heart Fail Rev. 2024, 29:1039-1047. 10.1007\/s10741-024-10417-7","journal-title":"Heart Fail Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-022-00348-6","article-title":"Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus","volume":"19","author":"Barbuskaite D","year":"2022","unstructured":"Barbuskaite D, Oernbo EK, Wardman JH, et al.. Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus. Fluids Barriers CNS. 2022, 19:53. 10.1186\/s12987-022-00348-6","journal-title":"Fluids Barriers CNS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323055-effectiveness-of-acetazolamide-in-patients-with-heart-failure-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T08:30:10Z","timestamp":1734337810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323055-effectiveness-of-acetazolamide-in-patients-with-heart-failure-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.75778","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,16]]}}}